减肥药市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00028374
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 182
Buy Now

减肥药市场预计将从2021年的11.3255亿美元增长到2028年的22.7094亿美元;预计 2021 年至 2028 年复合年增长率为 10.4%。

减肥药是与良好饮食和锻炼习惯结合使用的药片,可帮助人们减肥。有多种选择,但 NHS 认为大多数都是无效的。一些减肥药可能对帮助人们减肥毫无用处,而另一些可能有效,但食用起来太危险。含有芬特明和托吡酯的减肥片已被证明可以帮助人们减肥。自我护理的增加、肥胖问题的日益严重、老年人口的增加以及服用膳食补充剂的女性激增预计也将有助于减肥药市场规模的增长。

 
战略洞察

减肥药市场利润丰厚的区域

市场洞察

市场参与者推出新产品,推动减肥药市场

就现代医疗保健场景而言,肥胖是全球范围内的一个重大问题。肥胖会引起其他几种相关的慢性疾病,例如糖尿病和心血管疾病,这是人们主要关注的问题。使用特定的处方药和非处方药可能会帮助那些努力有效控制体重的人。该药物通过多种方式发挥作用,帮助有效控制体重。其中一些减肥药可能会阻止脂肪吸收并抑制食欲,以帮助控制体重。因此,肥胖患病率的增加和对肥胖的担忧预计将在预测期内支持减肥药市场的增长。

以下是一些公司推出新产品的示例减肥药及其发展:

  • 2022 年 2 月,Iovate Health Sciences International Inc. 在其全国公认的 Hydroxycut 减肥补充剂品牌下,宣布了一项新的美国全国品牌活动“No Fads”。只是减肥。”该活动旨在强调三步减肥之旅。
  • 2020 年 2 月,VIVUS LLC 和韩国营销合作伙伴 Alvogen 在韩国推出了 Qsymia(芬特明和托吡酯缓释剂) 。 VIVUS LLC 与韩国抗肥胖市场的知名领导者 Alvogen 签署协议,以高效且经济高效地最大化商业阶段资产的价值。

此类发展按市场划分参与者正在推动减肥药市场。

产品类型洞察

根据产品类型,全球减肥药市场分为处方药、超过柜台药物、草药补充剂。 2021年,处方药细分市场占据最大市场份额。然而,草药补充剂领域预计在 2021 年至 2028 年复合年增长率最高。人们对天然产品和预防性医疗保健的兴趣日益浓厚,以及健康和福祉方面的支出激增,是草药补充剂细分市场增长的主要驱动力。

减肥药市场(按产品类型) 2021年-2028年期间

应用洞察

根据应用,全球减肥药市场分为食欲抑制药、脂肪阻断药、促进新陈代谢药、和别的。 2021年,食欲抑制细分市场占据最大市场份额;预计 2021 年和 2028 年复合年增长率最高。抑制食欲的补充剂不含咖啡因或其他兴奋剂;然而,它可以增加能量和注意力。这个人更有可能坚持锻炼习惯,并以更多的精力保持健康的生活方式。因此,这些原因可能会在预测期内促进该细分市场的增长。

产品发布和合作是全球减肥药市场参与者高度采用的策略。下面列出了近期的一些关键市场动态:

  • 2021 年 12 月,辉瑞公司 (Pfizer Inc.) 以约 67 亿美元收购了 Arena Pharmaceuticals,以重塑其炎症药物组合。此外,辉瑞在收购更多资产方面拥有得天独厚的优势。
  • 2019 年 9 月,Currax Pharmaceuticals LLC 收购了 Nalpropion Pharmaceuticals, Inc。通过此次收购,Currax 拥有 CONTRAVE 的全球权利,这是美国的一种处方减肥品牌药物。

2020 年初,由于实验室暂时关闭,从事减肥药市场的公司的服务受到了不利影响。然而,封锁解除后,研究实验室在全球范围内重新开放。因此,许多服务提供商在 COVID-19 大流行期间优先考虑了消费者的一些关键行动,例如提供一系列高质量的 COVID-19 相关研究工具;重新分配研发资源以生产必需产品;扩大供应链;支持对 COVID-19 相关研究产品不断增长的需求;并在英国、美国和中国进行了集中于 SARS-CoV-2 诊断、药物和疫苗开发的讨论和合作。此外,在 COVID-19 疫情爆发后,用于免疫健康的膳食补充剂的销量有所增加。许多人希望这些产品能够保护消费者免受 SARS-CoV-2 感染,并减轻 COVID-19 患者的疾病严重程度。

然而,封锁扰乱了产品供应链并造成原料收集出现问题,对市场影响微乎其微。这种流行病正在影响该地区各个主要参与者的运营

减肥药–市场细分

全球减肥药市场根据产品类型、应用、年龄组、分销渠道和地理位置进行细分。根据产品类型,市场分为处方药、非处方药和草药补充剂。根据应用,减肥药市场分为抑制食欲药、脂肪阻断药、促进新陈代谢药等。根据年龄范围,减肥药市场分为青少年和成人。根据分销渠道,减肥药市场分为医院药房、网上药房和零售药房。药店。按地域划分,减肥药市场分为北美、欧洲、亚太地区、中东和非洲。非洲、南美和非洲中美洲。

公司简介

  • Novo Nordisk A/S
  • Gelesis
  • VIVUS LLC
  • Chong's Health Care
  • 葛兰素史克公司
  • 辉瑞公司 (Arena Pharmaceutical GmbH)
  • Iovate Health Sciences International Inc.
  • Zoller 实验室
  • Currax Pharmaceuticals LLC。
  • 梯瓦制药工业有限公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the diet pills market?

Diet pills are tablets that are used in conjunction with a good diet and exercise routine to help people lose weight. There are a variety of options, but the NHS considers most of them ineffective. Some diet pills may be useless in helping people lose weight, while others may be effective yet too dangerous to use. Phentermine and topiramate-containing weight loss tablets have been proved to help people lose weight.

What are the driving factors for the diet pills market across the country?

Factors such as the increase in self-directed care, rising problem of obesity, and increase in elderly population & surge in women taking dietary supplements are driving the market. However, the challenging regulatory environment is expected to restrict the market growth during the forecast period.

What are the driving factors for the diet pills market across the country?

The challenging regulatory environment is expected to restrict the market growth during the forecast period

Who are the major players in market the diet pills market?

The diet pills market majorly consists of the players such as Novo Nordisk A/S, Gelesis, VIVUS LLC, Chong's Health Care, GlaxoSmithKline plc., Pfizer Inc. (Arena Pharmaceutical GmbH), Iovate Health Sciences International Inc., Zoller Laboratories, Currax Pharmaceuticals LLC., TEVA PHARMACEUTICAL INDUSTRIES LTD.

Which segment is dominating the diet pills market?

The global diet pills market based on product type, is segmented into prescription, over the counter drugs, and herbal supplements. In 2021, prescription segment held largest market share. However, herbal supplements segment is estimated to grow at the fastest CAGR of 10.9% during the forecast period.

Which region is dominating the diet pills market?

The global diet pills market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 11.0% during the forecast period

The List Of Companies - Diet Pills Market

  1. Novo Nordisk A/S
  2. Gelesis
  3. VIVUS LLC
  4. Chong's Health Care
  5. GlaxoSmithKline plc.
  6. Pfizer Inc. (Arena Pharmaceutical GmbH)
  7. Iovate Health Sciences International Inc.
  8. Zoller Laboratories
  9. Currax Pharmaceuticals LLC.
  10. TEVA PHARMACEUTICAL INDUSTRIES LTD

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports